Text Size

Magnetically actuated glaucoma drainage device for regulating intraocular pressure after implantation

Pereira ICF, van Mechelen RJS, Wyss HM, Pinchuk L, Beckers HJM, den Toonder JMJ.


  • 2023
  • Microsyst Nanoeng.
View publication
  • Therapeutic Area

    Glaucoma

  • Technology

    Drug Delivery

  • Affiliations

    5600MB Eindhoven, The Netherlands Microsystems, Department of Mechanical Engineering, Eindhoven University of Technology; 5600MB Eindhoven, The Netherlands Institute for Complex Molecular Systems (ICMS), Eindhoven University of Technology; 6202AZ Maastricht, The Netherlands University Eye Clinic Maastricht, Maastricht University Medical Centre+ (MUMC+); InnFocus, Inc., a Santen Company, Miami, Florida 33186 USA; Miami, Florida 33136 USA Ophthalmic Biophysics Center, Bascom Palmer Eye Institute, University of Miami Miller School of Medicine.

Related Publications

Efficacy and Safety of a Preservative-Free Latanoprost Cationic Emulsion in Patients with Open-Angle Glaucoma and Concurrent Ocular Surface Disease: A Randomized Phase 2 Study.

Bacharach, Jason; McLaurin, Eugene B.; Silverstein, Steven; Amrane, Mourad; Garrigue, Jean-Sebastien; Ismail, Dahlia; Flynn, William J.; Catiolanze Phase 2 study group


Assessment of Brain-Derived Neurotrophic Factor on Retinal Structure and Visual Function in Rodent Models of Optic Nerve Crush

Taniguchi T.; Sharif N.A.; Ota T.; Farjo R.A.; Rausch R.


24-Hour Evaluation of the Effectiveness and Tolerability of Preservative-Free Tafluprost-Timolol Fixed Combination in Open-Angle Glaucoma or Ocular Hypertensive Patients Previously Treated with Preserved Latanoprost

Oddone F, Tanga L, Giammaria S, Sabbatini L, Strianese A, Ferrazza M, Rossetti LM


Can't find what you're looking for?

Contact us

Document number: NP-No product-EMEA-0110
Date of preparation: February 2022